SIK1 and metabolic dysfunction-associated steatotic liver disease: Recently, our research showed that ZQR significantly decreased fasting blood glucose (FBG), serum TG, serum TC and liver TG contents, while the hepatic expression of SIK1 was obviously upregulated by ZQR treatment in NAFLD rats with T2DM [28].